Antares Pharma traded at $5.59 this Monday May 23rd, decreasing $0 or 0 percent since the previous trading session. Looking back, over the last four weeks, Antares Pharma lost 0.54 percent. Over the last 12 months, its price rose by 37.01 percent. Looking ahead, we forecast Antares Pharma to be priced at 5.43 by the end of this quarter and at 4.99 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 141.29 -0.15 -0.11% 19.81%
Abbott 109.96 -0.59 -0.53% -12.54%
Adma Biologics 2.51 0.06 2.45% 104.07%
Aerie Pharmaceuticals 11.47 0.38 3.43% -18.42%
ANI Pharmaceuticals 35.84 -0.03 -0.08% 35.35%
Atrion 638.00 6.82 1.08% -6.38%
Becton, Dickinson and Co. 263.71 -0.52 -0.20% 6.39%
Cara Therapeutics 11.12 0.17 1.55% -10.39%
Cerus 4.82 -0.06 -1.23% -15.29%
Endo International 0.41 0.12 42.90% -88.57%
Horizon Pharma 61.21 -0.52 -0.84% -40.71%
Jazz Pharmaceuticals 156.55 -1.05 -0.67% 19.04%
Eli Lilly 316.72 -0.10 -0.03% 17.13%
OraSure Technologies 4.32 0.02 0.47% -57.23%
Pacira 58.12 -0.02 -0.03% 6.35%
Pfizer 48.58 -0.69 -1.40% -0.45%
Rockwell Medical 1.94 -0.11 -5.37% 238.33%
Revance Therapeutics 22.23 0.55 2.54% -14.20%
Sientra 0.91 -0.07 -7.01% -83.95%
STAAR Surgical 100.49 -0.14 -0.14% -27.50%
Supernus Pharmaceuticals 33.86 0.35 1.04% 43.84%
Teva Pharmaceutical Industries Ltd 3,275.00 -17.00 -0.52% 6.92%
Teva Pharmaceutical Industries 10.34 0.33 3.30% 12.15%
Utah Medical Products 92.90 -0.30 -0.32% 7.65%
Meridian Bioscience 33.00 0.08 0.24% 73.87%

Indexes Price Day Year
USND 12965 27.22 0.21% -10.84%
US2000 2001 13.41 0.68% -6.18%

Antares Pharma
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products and technologies. The Company develops, manufactures and commercialize, for itself or with partners, therapeutic products using its drug delivery systems. The Company products include XYOSTED, OTREXUP, NOCDURNA, Epinephrine Injection USP, Sumatriptan Injection USP, Makena and Teriparatide Injection. Its XYOSTED injection product for subcutaneous administration of testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Its OTREXUP is a subcutaneous methotrexate injection is a disposable auto injector, indicated for adults with severe active rheumatoid arthritis (RA), children with active polyarticular juvenile idiopathic arthritis and adults with severe recalcitrant psoriasis.